ArticleInternational journal of molecular sciences2022

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.

Dinah Linke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.